Are TAK insiders buying or selling?

Over the last 90 days, TAK insiders were net sellers, reporting $0.00 of open-market purchases and $13,088,586 of sales.

When was the last TAK insider purchase?

No open-market insider purchase of Takeda Pharmaceutical Co - ADR stock was reported in the last 90 days.

Where does TAK insider trading data come from?

Watch Insiders reads the SEC Form 4 filings that Takeda Pharmaceutical Co - ADR officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.

TAKSector not reported

Takeda Pharmaceutical Co - ADR (TAK) Insider Trading

In the last 90 days, 13 Takeda Pharmaceutical Co - ADR (TAK) insiders reported no open-market purchases and 19 sales totaling $13,088,586. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers: 0
90-day purchase value: $0.00
Corporate buyers: 0
Latest transaction: Sep 14, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
Date	Insider name	Role	Type	Shares	Price	Total value
Sep 14, 2026	Lauren Rusckowski Duprey	Chief Transformation Officer	Sale	34,535	$18.54	$640,279
Sep 2, 2026	Andrew Stewart Plump	President, R&D	Sale	116,191	$18.49	$2,148,372
Aug 19, 2026	Andrew Stewart Plump	President, R&D	Sale	19,651	$18.49	$363,347
Aug 18, 2026	Nicola Deidre Petal Greenway	Chief Human Resources Officer	Sale	12,980	$18.11	$235,118
Aug 11, 2026	Elaine Mary Shannon	Pres., Global Supply & Quality	Sale	20,363	$17.55	$357,371
Aug 10, 2026	Awny Samaan Botros Farajallah	Chief Medical Officer	Sale	14,006	$17.10	$239,503
Aug 10, 2026	Ramy Riad Ahmed Ibrahim	President, PDT BU	Sale	7,277	$17.10	$124,437
Aug 10, 2026	Rhonda Janice Pacheco	President, U.S. Business Unit	Sale	16,901	$17.10	$289,007
Aug 10, 2026	Lauren Rusckowski Duprey	Chief Transformation Officer	Sale	47,586	$17.10	$813,721
Aug 10, 2026	Andrew Stewart Plump	President, R&D	Sale	165,393	$17.10	$2,828,220
[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]
[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]

🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

TAK insider trading FAQ

Are TAK insiders buying or selling?: Over the last 90 days, TAK insiders were net sellers, reporting $0.00 of open-market purchases and $13,088,586 of sales.
When was the last TAK insider purchase?: No open-market insider purchase of Takeda Pharmaceutical Co - ADR stock was reported in the last 90 days.
Where does TAK insider trading data come from?: Watch Insiders reads the SEC Form 4 filings that Takeda Pharmaceutical Co - ADR officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.